Evolus (NASDAQ: EOLS) reported Q2 EPS of ($0.18), $0.13 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $66.9 million versus the consensus estimate of $64.93 million.

GUIDANCE:

Evolus sees FY2024 revenue of $260-270 million, versus the consensus of $262.2 million.

For earnings history and earnings-related data on Evolus (EOLS) click here.